Curing cancer in 20 years. Better detection for Lewy Body Dementia. Sequencing the genomes of newborns. All of these were discussed at Forbes’ 2016 Healthcare Summit last week. But the issue that reemerged most relentlessly throughout the day? Pricing.
The morning kicked off with a conversation between Express Scripts SVP and Chief Medical Officer Steve Miller, M.D., and Allergan CEO Brent Saunders, moderated by Forbes’ Matthew Herper. Saunders led with the announcement that Allergan would now cover drug expenses for patients with incomes up to 400 to 500% of the federal poverty level (you can read more about that announcement here).
